As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 470 Wildwood Ave, Woburn, MA 01801 (America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
We are excited to announce that Medicilon will be attending the Cell & Gene Therapy Annual Conference from June 17-18, 2022. Our CEO and the US Business Development team welcome you to join us at the conference! Please stop by our booth and chat how our services and capabilities would support your research needs and expedite your drug discovery and development programs. Wish you a safe trip!
Date: June 17-18, 2022
Location: Philadelphia, PA
About Medicilon
Medicilon is an integrated contract research organization (CRO), providing comprehensive innovative drug R&D for pharmaceutical enterprises and scientific research institutions worldwide. Medicilon has established a gene therapy- focused drug R&D platform providing services for evaluating efficacy, biodistribution, and safety research of cell and gene therapy products. At present, CAR-T, TCR-T, CAR-NK, oncolytic virus, antibodies (monoclonal antibodies, bispecific antibodies, polyclonal antibodies, etc.), siRNA, AAV, and other immunotherapy models and methods are used for evaluation of the efficacy of immunotherapy and empowering the research process of innovative therapies. Medicilon is AAALAC accredited as well as US FDA and CN NMPA certified.
Service Types
❖ Cell Therapy
❖ Oncolytic Virus
❖ Oligonucleotide
❖ Gene Editing
Service Models
❖ PDX Models
❖ Humanized Mouse Models
❖ Syngeneic Mouse Models
❖ Orthotopic Cancer Models
❖ Xenograft Models
Analysis Platform
❖ Nucleic Acid Level Analysis Platform
❖ qPCR, RT-qPCR, dPCR
❖ Cell Level Analysis Platform
❖ Cell-counter, FACS, ELISPOT, TCID50
❖ Protein Level Analysis Platform
❖ ELISA, FIA, CLIA, ECL, HTRF, RIA, Gyrolab, Bio-plex
Advanced Equipment
❖ CytoFLEX Flow Cytometer
❖ QIAcuity one Digital PCR Instrument
❖ Luminex, MSD Electro-chemiluminescence Analyzer
❖ MD SpectraM4/M5, ABI7500 qPCR
❖ Covaris E220, Kingfisher
About SAPA-GP
Based in the Greater Philadelphia tech corridor, SAPA-GP was founded by a group of passionate pharmaceutical professionals and researchers. SAPA-GP is a key source for knowledge exchange on the latest developments in the pharmaceutical, biotechnology, and generic drug industries, the hidden gem for pharmaceutical professionals in the Greater Philadelphia area, the bridge for the pharmaceutical and healthcare industries between China and USA. To learn more, please visit their website.